Ahmet Cingöz
@ahmetcingoz.bsky.social
Asst. Prof. / Brain Cancer Researcher.
Lab: @acingozlab.bsky.social
More info: http://about.me/ahmetcingoz
(Bird/wild life photographer | Calligraphy st.)
Lab: @acingozlab.bsky.social
More info: http://about.me/ahmetcingoz
(Bird/wild life photographer | Calligraphy st.)
Excited to share a new paper led by friend and colleague Betül Ersoy Fazlıoğlu! It shows how HOXB13 drives AR-negative prostate cancer via AP-1 and SMARCD2—revealing a therapeutic vulnerability. Great to contribute!
www.pnas.org/doi/10.1073/...
www.pnas.org/doi/10.1073/...
www.pnas.org
December 5, 2025 at 8:53 AM
Excited to share a new paper led by friend and colleague Betül Ersoy Fazlıoğlu! It shows how HOXB13 drives AR-negative prostate cancer via AP-1 and SMARCD2—revealing a therapeutic vulnerability. Great to contribute!
www.pnas.org/doi/10.1073/...
www.pnas.org/doi/10.1073/...
“The month’s sharpest science shots, selected by Nature’s photo team.” www.nature.com/immersive/d4...
The vibrant colours of a house-hunting crab — August’s best science image
The month’s sharpest science shots, selected by Nature’s photo team.
www.nature.com
September 2, 2025 at 11:21 AM
“The month’s sharpest science shots, selected by Nature’s photo team.” www.nature.com/immersive/d4...
🎉 Excited to share that a new article led by my colleague Özlem is now online!
In this study, she explored epigenetic vulnerabilities in Taxol-resistant triple-negative breast cancer using the CRISPR and chemical screening approach. 🧬🎗️
www.nature.com/articles/s12...
In this study, she explored epigenetic vulnerabilities in Taxol-resistant triple-negative breast cancer using the CRISPR and chemical screening approach. 🧬🎗️
www.nature.com/articles/s12...
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer - Experimental & Molecular Medicine
Triple-negative breast cancer (TNBC) is a challenging type of breast cancer that lacks targeted treatment options. Researchers aimed to understand why some TNBC cells become resistant to the chemother...
www.nature.com
July 1, 2025 at 8:15 AM
🎉 Excited to share that a new article led by my colleague Özlem is now online!
In this study, she explored epigenetic vulnerabilities in Taxol-resistant triple-negative breast cancer using the CRISPR and chemical screening approach. 🧬🎗️
www.nature.com/articles/s12...
In this study, she explored epigenetic vulnerabilities in Taxol-resistant triple-negative breast cancer using the CRISPR and chemical screening approach. 🧬🎗️
www.nature.com/articles/s12...
New preprint from my colleague Yağmur! She developed TMZ-resistant glioblastoma cells and identified key regulators using an epigenetics-focused CRISPR/Cas9 library screen. A great step towards understanding resistance mechanisms. 👏🧬🧠
#TBOLab
#BrainTumorStrong
#TBOLab
#BrainTumorStrong
Functional Genomic Screens Reveal RBBP4 as a Key Regulator of Cell Cycle Progression in TMZ-Resistant Glioblastoma https://www.biorxiv.org/content/10.1101/2025.05.09.653010v1
May 10, 2025 at 6:09 PM
New preprint from my colleague Yağmur! She developed TMZ-resistant glioblastoma cells and identified key regulators using an epigenetics-focused CRISPR/Cas9 library screen. A great step towards understanding resistance mechanisms. 👏🧬🧠
#TBOLab
#BrainTumorStrong
#TBOLab
#BrainTumorStrong
Merhaba. :) İlk paylaşımım (veya “skeet*”im) güzel İstanbul olsun. 🧡
Hello Bluesky family. :)
Let my first post (or skeet*) be beautiful Istanbul. 🧡
📷: AC, 30.4.25, Istanbul.
(*Bluesky tweet’iymiş.☺️)
Hello Bluesky family. :)
Let my first post (or skeet*) be beautiful Istanbul. 🧡
📷: AC, 30.4.25, Istanbul.
(*Bluesky tweet’iymiş.☺️)
May 8, 2025 at 5:10 PM
Merhaba. :) İlk paylaşımım (veya “skeet*”im) güzel İstanbul olsun. 🧡
Hello Bluesky family. :)
Let my first post (or skeet*) be beautiful Istanbul. 🧡
📷: AC, 30.4.25, Istanbul.
(*Bluesky tweet’iymiş.☺️)
Hello Bluesky family. :)
Let my first post (or skeet*) be beautiful Istanbul. 🧡
📷: AC, 30.4.25, Istanbul.
(*Bluesky tweet’iymiş.☺️)